Johnson & Johnson
Christine Cahillane, J.D., MBA, is a seasoned professional in regulatory affairs and legal support, currently serving as a Senior Regulatory Affairs Specialist at DePuy Synthes Power Tools, a division of Johnson & Johnson, since January 2022. Previously, Christine held the position of Regulatory Affairs Specialist II at DePuy Synthes Spine from September 2018 to January 2022, providing regulatory guidance for product development. Prior to this, Christine worked as a Paralegal II at Resolute Management, Inc. and Liberty Mutual Insurance Company, where responsibilities included managing document reviews and producing litigation materials. Early career experience includes serving as an Associate Attorney at Lyon & Fitzpatrick, LLP, focusing on civil litigation and various legal matters. Christine holds a Doctor of Law (J.D.) from Suffolk University Law School, an MBA from Suffolk University - Sawyer Business School, and a Bachelor of Arts in English from Saint Anselm College.
This person is not in any teams
This person is not in any offices
Johnson & Johnson
535 followers
Johnson & Johnson and its subsidiaries have approximately 141,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. Johnson & Johnson is organized into three business segments: Consumer Health, Pharmaceutical and Medical Devices. The Consumer Health segment includes a broad range of products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology (e.g., rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and psoriasis), Infectious Diseases (e.g., HIV/AIDS and COVID-19), Neuroscience (e.g., mood disorders, neurodegenerative disorders and schizophrenia), Oncology (e.g., prostate cancer, hematologic malignancies, lung cancer and bladder cancer), Cardiovascular and Metabolism (e.g., thrombosis, diabetes and macular degeneration) and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals and healthcare professionals for prescription use. The Medical Devices segment includes a broad range of products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields. At Johnson & Johnson, employees are guided by Our Credo which sets forth the Company’s responsibilities to patients, consumers, customers, healthcare professionals, employees, communities and shareholders. The Company is committed to workplace diversity and to cultivating, fostering, and advancing a culture of equity and inclusion. Enabling employees to perform at their best while being themselves is fundamental to the Company’s continued success. The Company’s DEI vision is: Be yourself, change the world.